The current study suggested that TERT promoter mutations more likely tended to present in older patients with FTC, and were only associated with distant metastasis and advanced TNM stage, but not with gender, tumor size, multifocality, vascular invasion, extrathyroidal extension, and LNM. The gene discussed is TERT; the disease is thyroid cancer, nonmedullary, 2.